Fore Capital LLC purchased a new stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 30,000 shares of the company's stock, valued at approximately $1,190,000.
A number of other large investors have also recently made changes to their positions in ACHC. Wellington Management Group LLP lifted its holdings in Acadia Healthcare by 12.2% in the third quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company's stock valued at $739,250,000 after acquiring an additional 1,266,384 shares during the period. JPMorgan Chase & Co. increased its position in shares of Acadia Healthcare by 17.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock valued at $198,258,000 after purchasing an additional 454,044 shares during the last quarter. State Street Corp lifted its stake in shares of Acadia Healthcare by 3.5% in the 3rd quarter. State Street Corp now owns 2,819,911 shares of the company's stock worth $178,811,000 after purchasing an additional 95,613 shares during the period. Point72 Asset Management L.P. grew its position in Acadia Healthcare by 0.5% during the third quarter. Point72 Asset Management L.P. now owns 2,282,810 shares of the company's stock valued at $144,753,000 after buying an additional 12,470 shares during the period. Finally, Geode Capital Management LLC increased its holdings in Acadia Healthcare by 0.9% during the third quarter. Geode Capital Management LLC now owns 1,613,198 shares of the company's stock valued at $102,320,000 after buying an additional 14,197 shares during the last quarter.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on the stock. Cantor Fitzgerald reissued a "neutral" rating and set a $52.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Bank of America decreased their price objective on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research note on Friday, February 28th. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a "hold" rating to a "buy" rating and boosted their price objective for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. Barclays cut shares of Acadia Healthcare from an "overweight" rating to an "equal weight" rating and decreased their target price for the stock from $43.00 to $35.00 in a research note on Friday, February 28th. Finally, StockNews.com cut shares of Acadia Healthcare from a "hold" rating to a "sell" rating in a research note on Monday, January 6th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, Acadia Healthcare presently has a consensus rating of "Hold" and a consensus price target of $56.31.
Check Out Our Latest Stock Analysis on ACHC
Acadia Healthcare Price Performance
Shares of ACHC stock traded up $0.89 during mid-day trading on Monday, hitting $29.43. The company had a trading volume of 1,198,494 shares, compared to its average volume of 1,315,429. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The stock's 50 day moving average price is $40.15 and its 200-day moving average price is $48.31. Acadia Healthcare Company, Inc. has a 52-week low of $27.61 and a 52-week high of $82.41. The company has a market capitalization of $2.73 billion, a P/E ratio of 9.65, a P/E/G ratio of 1.46 and a beta of 1.38.
Acadia Healthcare Profile
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Recommended Stories

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.